-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Procurement Announcement of the National Alliance of Proprietary Chinese Medicines (No.
Formed the National Joint Procurement Office of Proprietary Chinese Medicines (hereinafter referred to as the Joint Procurement Office)
There are several key messages in this article:
There are several key messages in this article1.
Joint Procurement Office of Proprietary Chinese Medicines
2.
3.
The monitoring and management of the unselected products included in the alliance area shall not exceed 10% of the actual procurement volume of the same procurement group.
Table 1: The size of hospitals sampled by product samples in Hubei proprietary Chinese medicine in 2022
Table 1
(Source: Yaorongyun IMS Mine et al.
The scale of 2022 is the scale of H1 review
Table 2: Information on the product group of this design and its corresponding manufacturers
(Source: Yaorongyun IMS Mine et al.
Special note: The above manufacturer information is available for checkable sales data (data regardless of size),
Special instructionsTable 3: The rules related to the first batch of proprietary Chinese medicines in Hubei Province, the following is the summary and quotation analysis of the rules of the first batch of proprietary Chinese medicines with quantity collection alliances
The procurement volume of nearly 1.
Hubei Proprietary Chinese Medicine Provincial Alliance No.
Hubei proprietary Chinese medicine with volume collection on the 21st quotation, group A quotation analysis and median discussion
Brief review
Brief review1.
1.
2, each group of manufacturers is not fierce
The overall competitive pattern is relatively ideal, and if the competition pattern is smaller, the overall quotation logic is expected to change; That is to say, the median and average decline of the last time should be appropriately reduced
That is to say, the median and average decline of the last time should be appropriately reduced when making references
Specific how to quote analysis, wait for the rules to come out, want to see the first batch, the previous links of several articles have been written
3, the amount of influence grouping: last year is the first year that everyone may not be able to adapt, now there is the first batch of Hubei, Guangdong grand alliance once, the proprietary Chinese medicine companies should be more experienced
3.
The amount of reporting is not expensive
.
4.
Preparations for national linkage: Will the first batch of national linkage/expansion be opened in the second half of 2022? In any case, the trend of convergence of national price/medical insurance payment standards for proprietary Chinese medicines with quantity collection is inevitable and will definitely come, and now it is definitely necessary to prepare for
a certain market, scale and decline.
Preparation for national linkage
5, the price and specifications of the trade-off: after the directory is published, it is definitely necessary to declare the enterprise information, for the amount of reporting, the decline and the corresponding specifications, the enterprise can consider, which is related
to the price linkage mechanism of the Kwa Alliance and the Kwa Province with the amount of mining.
The trade-off between price and specification
The same variety hubei in the A specification, Guangdong in the B specification, then, the impact of A and B has a "difference"
.
The rest will be just waiting for the rules to be introduced!!! The follow-up Fengyun Pharmaceutical Talk will track the second batch of relevant information, and the data and quotation prediction analysis
will be done before the quotation.
